Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidanc...(ax 0.04 (0.01) Adjus...)

Adjusted EPS (b) $2.65 $1.91

Segment Data Twelve Months Ended

December December

31, % of 31, % of

(In millions except percentage 2007 Revenues 2006 Revenues

amounts)

Revenues

Analytical Technologies $4,256.0 43.7% $2,425.8 64.0%

Laboratory Products and Services 5,842.2 59.9% 1,406.6 37.1%

Eliminations (351.8) -3.6% (40.8) -1.1%

Consolidated Revenues $9,746.4 100.0% $3,791.6 100.0%

Operating Income and Operating Margin

Analytical Technologies $843.1 19.8% $383.7 15.8%

Laboratory Products and Services 793.8 13.6% 189.2 13.5%

Subtotal Reportable Segments 1,636.9 16.8% 572.9 15.1%

Cost of Revenues Charges (c) (49.2) -0.5% (77.7) -2.0%

Restructuring and Other Costs, Net

(d) (42.2) -0.4% (45.7) -1.2%

Equity Compensation Acceleration

Charge (e) - 0.0% (36.7) -1.0%

Amortization of Acquisition-related

Intangible Assets (571.1) -5.9% (170.8) -4.5%

GAAP Operating Income (a) $974.4 10.0% $242.0 6.4%

Pro Forma Data (unaudited) (k) Twelve Months Ended

December 31, % of

(In millions except percentage amounts) 2006 Revenues

Pro Forma Revenues (k)

Analytical Technologies $3,742.5 42.2%

Laboratory Products and Services 5,437.6
'/>"/>